Skip to content

Comparison of Cognitive Behavioral Group therapy's Efficacy Versus Hypnotherapy on decreasing signs of social phobia and patients' brain/behavioral systems changes.

Comparison of Cognitive Behavioral Group therapy's Efficacy Versus Hypnotherapy on decreasing signs of social phobia and patients' brain/behavioral systems changes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015121425523N1
Enrollment
30
Registered
2017-01-15
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social phobia. Social phobias

Interventions

Intervention 1: Experimental Group 1: Cognitive-behavioral group therapy for social phobia Following Protocol is going to be used: A Brief Cognitive-Behavioral Treatment for Social Anxiety Disorder E
on the left, the automatic thoughts are recorded, using examples from the class and on the right, the types of situations that elicit the thought, An introduction to how thoughts affect the subsequent
Treatment - Other
Experimental Group 1: Cognitive-behavioral group therapy for social phobia Following Protocol is going to be used: A Brief Cognitive-Behavioral Treatment for Social Anxiety Disorder Eric P. Morri
Experimental Group 2: Group Hypnotherapy for social phobia the following group will receive 4 sessions of hypnotherapy within 4 weeks and the protocol is self-structured and approved by The Iranian

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.Having DSM-5 diagnostic criteria for social phobia 2.Getting psychiatric diagnosis of Social Phobia based on diagnostic interviews by Psychiatrist or Clinical Psychologist. 3. Subject's Score on SPIN questionnaire 4. Participants should not have received any treatments 6 month prior to beginning of the study. 5. participants should not received any medication one month prior to beginning of the study. 6. Participants should have a minimum age of 18 and maximum age of 50 years old. 7. Participants Should be at least on a undergraduate program. 8. Participants should agree to participation principals of the study and sign a written consent. Exclusion criteria: 1. having a psychotic disorder and or substance abuse based on diagnostic interview. 2. having full criteria of personality disorder diagnosis on Axis II based on diagnostic interview. 3. Being absent for more than one session of therapy course.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Social Phobia. Timepoint: Before intervention, after intervention, 1 month after intervention. Method of measurement: SPIN questionnaire.

Secondary

MeasureTime frame
Depression. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: DASS-21 Questionnaire.;Physiologic symptoms of Anxiety. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: BAI Questionnaire.;Anxiety. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: DASS-21 Questionnaire.;Avoidance Signs of Anxiety. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: SAD Questionnaire.;General function. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: GAF Scale.;Quality of life. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: WHOQOL- BREF Questionnaire.;Brain/Behavioral System changes. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: GWPQ Questionnaire.;Fear of negative evaluation. Timepoint: before intervention, after intervention, one month after intervention. Method of measurement: FNESB Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGolnaz Forouzandehfar

Zanjan University of Medical Sciences

g_forouzandehfar@yahoo.com; forouzandehfarg2@mums.ac.ir; gforouzandehfar@zums.ac.ir+98 24 3354 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026